Form D · Venture Capital Fund
AVSF - Surge Therapeutics 2023, LLC
Boston, MA · CIK 0001982296
Offering snapshot reported Oct 24, 2023 · SEC filing
- Reported sold
- $2.93M Offering amount: $2.93M
- Investors reported
- 207 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Jun 9, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$2,373,500 → $2,931,500
- Reported investors167 → 207
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 24, 2023 | Amendment | $2,931,500 | $558,000vs Jun 23, 2023 | 207 | SEC filing |
| Jun 23, 2023 | Initial | $2,373,500 | No comparison | 167 | SEC filing |
Offering details
- Securities
- Equity, Pooled investment fund
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-484977
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Oct 24, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
The linked fund shows its most recently reported ADV details.
Matched by reported Form D file number
AVSF - SURGE THERAPEUTICS 2023
Investment adviser: ALUMNI VENTURES, LLC
- Gross asset value
- $2.35M
- Beneficial owners
- 206
- ADV minimum commitment
- $5K
Reported in Form ADV on Mar 24, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.
Service providers
No provider names available in this fund's imported disclosure.
Provider details
- Annual audit
- No
- Prime brokers
- No
- Custodians
- No
- Administrator other than the adviser
- No
- External marketing
- No
Filing source
Form ADV 2067584 · Mar 24, 2026 · Schedule D 7.B.(1), fund 805-5916245342
Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Collins | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:Boston, MA, 02110